Skip to content
2000
Volume 25, Issue 17
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The growing prevalence of multidrug resistance and its detrimental effects pose a significant threat to public health, which is one reason for the current interest in the introduction of novel agents. To combat this adverse effect and drug resistance, numerous drugs have been developed over time, and their safety is still being evaluated; derivatives or medications based on the carbazole moiety are one of the key contributors. Therefore, this review explores carbazole-based derivatives as possible drugs to treat Alzheimer's, diabetes, inflammation, cancer, and many more, along with their synthetic schemes, SARs, and activity. Some of the carbazole-based drugs available in the market and under clinical trials are also tabulated. By integrating this insight, describe how these compounds are being reinvented as targeted therapeutic agents. This comprehensive analysis is designed to guide researchers in developing next-generation drugs to address various challenges and leverage the unique pharmacological properties of carbazole-derived drugs.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/mrmc/10.2174/0113895575407122250822095143
2025-09-02
2026-02-23

  • From This Site

    /content/journals/mrmc/10.2174/0113895575407122250822095143
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SchmidtA.W. ReddyK.R. KnölkerH.J. Occurrence, biogenesis, and synthesis of biologically active carbazole alkaloids.Chem. Rev.201211263193332810.1021/cr200447s 22480243
     [Google Scholar]
  2. KaplancikliZ.A. YurttaşL. Turan-ZitouniG. ÖzdemirA. ÖzicR. Ulusoylar-YıldırımŞ. Synthesis, antimicrobial activity and cytotoxicity of some new carbazole derivatives.J. Enzyme Inhib. Med. Chem.201227686887410.3109/14756366.2011.622273 21999633
     [Google Scholar]
  3. Zur AbwehrG.C. Zur abwehr.Ber. Dtsch. Chem. Ges.18725296896910.1002/cber.187200502112
     [Google Scholar]
  4. ChakrabortyD.P. RoyS Carbazole alkaloids IV.Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products Wien GmbHChamSpringer-Verlag20038512523010.1007/978‑3‑7091‑6051‑0_3
     [Google Scholar]
  5. MustafaY.F. MohammedN.A. A promising oral 5-fluorouracil prodrug for lung tumor: Synthesis, characterization and release.Biochem. Cell. Arch.202121Supplement. 119911999
     [Google Scholar]
  6. BashirM. BanoA. IjazA. ChaudharyB. Recent developments and biological activities of N-substituted carbazole derivatives: A review.Molecules2015208134961351710.3390/molecules200813496 26213906
     [Google Scholar]
  7. KasimS.M. Al-DabbaghB.M. MustafaY.F. A review on the biological potentials of carbazole and its derived products.Eurasian Chem. Commun.202246495512
     [Google Scholar]
  8. IssaS. WalchshoferN. KassabI. TermossH. ChamatS. GeahchanA. BouazizZ. Synthesis and antiproliferative activity of oxazinocarbazole and N,N-bis(carbazolylmethyl)amine derivatives.Eur. J. Med. Chem.20104562567257710.1016/j.ejmech.2010.02.045 20236739
     [Google Scholar]
  9. KnölkerH.J. ReddyK.R. Biological and pharmacological activities of carbazole alkaloids.Alkaloids Chem. Biol.20086518119310.1016/S1099‑4831(07)00004‑1
     [Google Scholar]
  10. IndumathiT. FronczekF.R. Rajendra PrasadK.J. Synthesis of 2-amino-8-chloro-4-phenyl-5,11-dihydro-6H-pyrido[2,3-a]carbazole-3-carbonitrile: Structural and biological evaluation.J. Mol. Struct.2012101613413910.1016/j.molstruc.2012.01.032
     [Google Scholar]
  11. MustafaY.F. BashirM.K. OglahM.K. Original and innovative advances in the synthetic schemes of coumarin-based derivatives: A review.Syst. Rev. Pharm.2020116598612
     [Google Scholar]
  12. LiJ.J. Bucherer carbazole synthesis.2006Available from: https://en.wikipedia.org/wiki/Bucherer_carbazole_synthesis
  13. ZhangH. ZhangR.H. WangL.X. LiY.J. LiaoS.G. ZhouM. Synthesis strategies for α‐, β‐, γ‐ and δ‐carbolines.Asian J. Org. Chem.202110342945210.1002/ajoc.202000690
     [Google Scholar]
  14. CreenciaE.C. KosakaM. MuramatsuT. KobayashiM. IizukaT. HoraguchiT. Microwave‐assisted Cadogan reaction for the synthesis of 2‐aryl‐2 H‐indazoles, 2‐aryl‐1 H‐benzimidazoles, 2‐carbonylindoles, carbazole, and phenazine.J. Heterocycl. Chem.20094661309131710.1002/jhet.267
     [Google Scholar]
  15. StokesB.J. JovanovićB. DongH. RichertK.J. RiellR.D. DriverT.G. Rh(2)(II)-catalyzed synthesis of carbazoles from biaryl azides.J. Org. Chem.20097483225322810.1021/jo9002536 19296584
     [Google Scholar]
  16. HungT.Q. DangT.T. LangerP. DoH.N. QuanN.M. Van PhucB. Van TinhD. TienN.Q. NgaT.T.T. NguyenV.T. Efficient copper-Catalysed synthesis of carbazoles by double N-arylation of primary amines with 2, 2′-dibromobiphenyl in the presence of air.Synlett202132661161510.1055/s‑0040‑1706641
     [Google Scholar]
  17. JamesM.J. ClubleyR.E. PalateK.Y. ProcterT.J. WytonA.C. O’BrienP. TaylorR.J.K. UnsworthW.P. Silver (I)-catalyzed dearomatization of alkyne-tethered indoles: Divergent synthesis of spirocyclic indolenines and carbazoles.Org. Lett.201517174372437510.1021/acs.orglett.5b02216 26293968
     [Google Scholar]
  18. QiuY. KongW. FuC. MaS. Carbazoles via AuCl 3 -Catalyzed cyclization of 1-(Indol-2-yl)-3-alkyn-1-ols.Org. Lett.201214246198620110.1021/ol3029498 23228044
     [Google Scholar]
  19. SamalaS. MandadapuA.K. SaifuddinM. KunduB. Gold-catalyzed sequential alkyne activation: One-pot synthesis of NH-carbazoles via cascade hydroarylation of alkyne/6-endo-dig carbocyclization reactions.J. Org. Chem.201378136769677410.1021/jo400799b 23789909
     [Google Scholar]
  20. SharmaS. ChauhanA. RanjanA. MathkorD.M. HaqueS. RamniwasS. TuliH.S. JindalT. YadavV. Emerging challenges in antimicrobial resistance: Implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability.Front. Microbiol.202415140316810.3389/fmicb.2024.1403168 38741745
     [Google Scholar]
  21. SharmaM. BakshiA.K. MittapellyN. GautamS. MarwahaD. RaiN. SinghN. TiwariP. AgarwalN. KumarA. MishraP.R. Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer.J. Cont. Rel.20223464370
     [Google Scholar]
  22. RochesterC.D. AkiyodeO. Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient.World J. Diabetes20145330531510.4239/wjd.v5.i3.305 24936252
     [Google Scholar]
  23. AlhazmiH.A. AlbrattyM. An update on the novel and approved drugs for Alzheimer disease.Saudi. Pharm. J.202230121755176410.1016/j.jsps.2022.10.004 36601504
     [Google Scholar]
  24. National center for biotechnology information.2021 Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Carbazole
  25. Ondansetron.2015 Available from: https://go.drugbank.com/drugs/DB00904
  26. Carvedilol.2011 Available from: https://go.drugbank.com/drugs/DB01136
  27. Ellipticine.2006 Available from: https://go.drugbank.com/drugs/DB17026
  28. MedKoo biosciences.2021 Available from: https://www.medkoo.com/products/6078
  29. Carprofen.2019 Available from: https://go.drugbank.com/drugs/DB00821
  30. Staurosporine.2019 Available from: https://go.drugbank.com/drugs/DB02010
  31. Midostaurin.2017 Available from: https://go.drugbank.com/drugs/DB06595
  32. Olivacine is an alkaloid with antitumor and antileukemic activity isolated from Aspidosperma olivaceum.2021 Available from: https://www.medkoo.com/products/35099
  33. Datelliptium chloride is a DNA-intercalating agent derived from ellipticine; Datelliptium chloride showed anti-tumor activities. Available from: https://www.medkoo.com/products/34055
  34. Carazostatin is an antioxidant, free radical scavenger and potent inhibitor of lipid peroxidation. Available from: https://www.medkoo.com/products/20868
  35. Chiglitazar.2024 Available from: https://go.drugbank.com/drugs/DB19023
  36. Pegcantratinib2024 Available from: https://go.drugbank.com/drugs/DB16280
  37. 7-Hydroxystaurosporine2019 Available from: https://go.drugbank.com/drugs/DB01933
  38. CHEBI:138650 - CBL01372021 Available from: https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:138650
  39. ESK9812024 Available from: https://go.drugbank.com/drugs/DB18155
  40. CEP-13472019 Available from: https://go.drugbank.com/drugs/DB05403
  41. Alectinib2015 Available from: https://go.drugbank.com/drugs/DB11363
  42. Ramatroban2019 Available from: https://go.drugbank.com/drugs/DB13036
  43. BegleyC.G. EllisL.M. Raise standards for preclinical cancer research.Nature2012483739153153310.1038/483531a 22460880
     [Google Scholar]
  44. HanahanD. WeinbergR.A. Hallmarks of cancer: The next generation.Cell2011144564667410.1016/j.cell.2011.02.013 21376230
     [Google Scholar]
  45. PiñerosM. MeryL. SoerjomataramI. BrayF. Steliarova-FoucherE. Scaling up the surveillance of childhood cancer: A global roadmap.J. Natl. Cancer Inst.2021113191510.1093/jnci/djaa069 32433739
     [Google Scholar]
  46. PradhanS. BacollaA. WellsR.D. RobertsR.J. Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation.J. Biol. Chem.199927446330023301010.1074/jbc.274.46.33002 10551868
     [Google Scholar]
  47. LiuJ. RuanM. LiuY. HongX. ZhangL. ZhangQ. Identification of 3-(9H-carbazol-9-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoic acids as promising DNMT1 inhibitors.Eur. J. Med. Chem.202427411653810.1016/j.ejmech.2024.116538 38823264
     [Google Scholar]
  48. ZhuW. ChenC. SunC. XuS. WuC. LeiF. XiaH. TuQ. ZhengP. Design, synthesis and docking studies of novel thienopyrimidine derivatives bearing chromone moiety as mTOR/PI3Kα inhibitors.Eur. J. Med. Chem.201593647310.1016/j.ejmech.2015.01.061 25659752
     [Google Scholar]
  49. XuS. SunC. ChenC. ZhengP. ZhouY. ZhouH. ZhuW. Synthesis and biological evaluation of novel 8-morpholinoimidazo [1, 2-a] pyrazine derivatives bearing phenylpyridine/phenylpy-rimidine-carboxamides.Molecules201722231010.3390/molecules22020310 28218676
     [Google Scholar]
  50. SunC. ChenC. XuS. WangJ. ZhuY. KongD. TaoH. JinM. ZhengP. ZhuW. Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives bearing chromone moiety.Bioorg. Med. Chem.201624163862386910.1016/j.bmc.2016.06.032 27353887
     [Google Scholar]
  51. WangQ. LiX. SunC. ZhangB. ZhengP. ZhuW. XuS. Synthesis and structure–activity relationships of 4-morpholino-7,8-dihydro-5h-thiopyrano[4,3-d]pyrimidine derivatives bearing pyrazoline scaffold.Molecules20172211187010.3390/molecules22111870 29088090
     [Google Scholar]
  52. Çapanİ. HawashM. QaoudM.T. GülümL. TunogluE.N.Y. ÇifciK.U. ÇevrimliB.S. SertY. ServiS. Kocaİ. TutarY. Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agents.BMC Chem.202418110210.1186/s13065‑024‑01207‑1 38773663
     [Google Scholar]
  53. WarfelN.A. KraftA.S. PIM kinase (and Akt) biology and signaling in tumors.Pharmacol. Ther.2015151414910.1016/j.pharmthera.2015.03.001 25749412
     [Google Scholar]
  54. AsatiV. AgarwalS. MishraM. DasR. KashawS.K. Structural prediction of novel pyrazolo-pyrimidine derivatives against PIM-1 kinase: In-silico drug design studies.J. Mol. Struct.2020121712837510.1016/j.molstruc.2020.128375
     [Google Scholar]
  55. AsatiV. MahapatraD.K. BhartiS.K. PIM kinase inhibitors: Structural and pharmacological perspectives.Eur. J. Med. Chem.20191729510810.1016/j.ejmech.2019.03.050 30954777
     [Google Scholar]
  56. ChenC.H. XuM.J. ZhengQ. LiD.D. ChengL. SunJ. WuZ.M. Biological evaluation of carbazoyl hydrazine derivatives as potential Pim-1 kinase inhibitors for the treatment of human liver cancer.J. Mol. Struct.2024129513674210.1016/j.molstruc.2023.136742
     [Google Scholar]
  57. RajenderO. PallaviH. SultanaR. Synthesis, characterization, DNA-binding, and anticancer activity of 7-methoxytetrahydropyrrolo[3,4-a]carbazole-1,3-diones derivatives with different hydroxyl-alkyl side chains.Russ. J. Bioorganic Chem.20245031082109310.1134/S1068162024080223
     [Google Scholar]
  58. WangJ.C. Cellular roles of DNA topoisomerases: A molecular perspective.Nat. Rev. Mol. Cell Biol.20023643044010.1038/nrm831 12042765
     [Google Scholar]
  59. WangJ.C. DNA topoisomerases.Annu. Rev. Biochem.199665163569210.1146/annurev.bi.65.070196.003223 8811192
     [Google Scholar]
  60. ForterreP. GribaldoS. GadelleD. SerreM.C. Origin and evolution of DNA topoisomerases.Biochimie200789442744610.1016/j.biochi.2006.12.009 17293019
     [Google Scholar]
  61. BaillyC. Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy.Chem. Rev.201211273611364010.1021/cr200325f 22397403
     [Google Scholar]
  62. OlszewskiM. MaciejewskaN. KallingalA. ChylewskaA. DąbrowskaA.M. BiedulskaM. MakowskiM. PadrónJ.M. BaginskiM. Palindromic carbazole derivatives: Unveiling their antiproliferative effect via topoisomerase II catalytic inhibition and apoptosis induction.J. Enzyme Inhib. Med. Chem.2024391230292010.1080/14756366.2024.2302920 38221785
     [Google Scholar]
  63. MénardS. PupaS.M. CampiglioM. TagliabueE. Biologic and therapeutic role of HER2 in cancer.Oncogene200322426570657810.1038/sj.onc.1206779 14528282
     [Google Scholar]
  64. BeniwalS.C. VirmaniT. Synthesis, characterization and evaluation of novel carbazole boronic acid derivatives in the treatment of breast cancer.Int. J. Pharm. Sci. Res.20231419922001
     [Google Scholar]
  65. UllahH. RahimF. UddinI. KhanM.U. KhanF. HussainA. HussainR. KhanS. Synthesis, in vitro α-amylase activity and molecular docking study of benzoxazole derivatives.Chemical Data Collections20245110113310.1016/j.cdc.2024.101133
     [Google Scholar]
  66. HuntingtonG.B. HarmonD.L. RichardsC.J. Sites, rates, and limits of starch digestion and glucose metabolism in growing cattle1.J. Anim. Sci.200684Suppl. 13E14E2410.2527/2006.8413_supplE14x 16582085
     [Google Scholar]
  67. ZahraS. ZaibS. KhanI. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.Int. J. Biol. Macromol.2024259Pt 212924110.1016/j.ijbiomac.2024.129241 38199537
     [Google Scholar]
  68. Diabetes.2024Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
  69. SohrabiM BinaeizadehMR IrajiA LarijaniB SaeediM MahdaviM A review on α-glucosidase inhibitory activity of first row transition metal complexes.A futuristic strategy for treatment of type 2 diabetes.202212191201112052
     [Google Scholar]
  70. TahaM. IrshadM. ImranS. RahimF. SelvarajM. AlmandilN.B. MosaddikA. ChigurupatiS. NawazF. IsmailN.H. IbrahimM. Thiazole based carbohydrazide derivatives as α -Amylase inhibitor and their molecular docking study.Heteroatom Chem.2019201911810.1155/2019/7502347
     [Google Scholar]
  71. ShahzadD. SaeedA. LarikF.A. ChannarP.A. AbbasQ. AlajmiM.F. ArshadM.I. ErbenM.F. HassanM. RazaH. SeoS.Y. El-SeediH.R. Novel C-2 symmetric molecules as α-glucosidase and α-amylase inhibitors: Design, synthesis, kinetic evaluation, molecular docking and pharmacokinetics.Molecules2019248151110.3390/molecules24081511 30999646
     [Google Scholar]
  72. Çapanİ. HawashM. QaoudM.T. JaradatN. Next-generation carbazole-linked 1,2,4-Triazole-thione derivatives: Strategic design, synthesis, molecular docking, and evaluation of antidiabetic potential.ACS Omega202510184886110.1021/acsomega.4c07896 39829592
     [Google Scholar]
  73. LuoS. ZhaoL. PengH. PengZ. WangG. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation.Eur. J. Med. Chem.202427511660010.1016/j.ejmech.2024.116600 38889608
     [Google Scholar]
  74. Uslu UçarT.N. BingulM. SahinH. KandemirH. SengulI.F. Synthesis of furo[2,3-c]carbazoles as potent α -glucosidase and α -amylase inhibitors.Synth. Commun.202454191698170610.1080/00397911.2024.2401628
     [Google Scholar]
  75. HassineK. ZridaH. SaidiI. HrizK. HamdanK. Ben JannetH. MajdoubH. Novel functionalized triazole/carbazole-based chitosan: In vitro, in vivo and in silico evaluation of anti-diabetic and anti-obesity activities.Chemistry Africa20247264365910.1007/s42250‑023‑00790‑5
     [Google Scholar]
  76. ŞahinH. Arslantürk BingülA. Şengülİ. BingülM. Biological and computational evaluation of carbazole-based bis-thiosemicarbazones: A selective enzyme inhibition study between α-amylase and α-glucosidase. İstanbul J.Phar2023531394410.26650/IstanbulJPharm.2023.1164443
     [Google Scholar]
  77. TinkovA.A. BjørklundG. SkalnyA.V. HolmgrenA. SkalnayaM.G. ChirumboloS. AasethJ. The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: Towards a possible prognostic marker?Cell. Mol. Life Sci.20187591567158610.1007/s00018‑018‑2745‑8 29327078
     [Google Scholar]
  78. KentrupH. BeckerW. HeukelbachJ. WilmesA. SchürmannA. HuppertzC. KainulainenH. JoostH.G. Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII.J. Biol. Chem.199627173488349510.1074/jbc.271.7.3488 8631952
     [Google Scholar]
  79. SongW.J. SternbergL.R. Kasten-SportèsC. KeurenM.L.V. ChungS.H. SlackA.C. MillerD.E. GloverT.W. ChiangP.W. LouL. KurnitD.M. Isolation of human and murine homologues of the Drosophila minibrain gene: Human homologue maps to 21q22.2 in the Down syndrome “critical region”.Genomics199638333133910.1006/geno.1996.0636 8975710
     [Google Scholar]
  80. LiA. GuanL. SuW. ZhaoN. SongX. WangJ. TangX. LiW. JiaoX. TXNIP inhibition in the treatment of type 2 diabetes mellitus: Design, synthesis, and biological evaluation of quinazoline derivatives.J. Enzyme Inhib. Med. Chem.2023381216693710.1080/14756366.2023.2166937 36651294
     [Google Scholar]
  81. GuanL. LiA. SongP. SuW. ZhangS. ChenJ. JiaoX. LiW. Design, synthesis, and biological evaluation of β-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes.Bioorg. Chem.202415110767610.1016/j.bioorg.2024.107676 39068716
     [Google Scholar]
  82. SuW. GuanL. ZhaoJ.N. HeZ.L. SongP. LiA. LiW. JiaoX. Design, synthesis and biological evaluation of quinazolinecarbazole derivatives as potent dual txnip/dyrk1a inhibitors for the treatment of type 2 diabetes mellitus.2024Available from: https://www.researchgate.net/publication/383325126_Design_Synthesis_and_Biological_Evaluation_of_Quinazoline-_Carbazole_Derivatives_as_Potent_Dual_TXNIP/DYRK1A_Inhibitors_for_the_Treatment_of_Type_2_Diabetes_Mellitus
  83. AnandP. SinghB. SinghN. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease.Bioorg. Med. Chem.20122031175118010.1016/j.bmc.2011.12.042 22257528
     [Google Scholar]
  84. Dementia.2025Available from: https://www.who.int/news-room/fact-sheets/detail/dementia
  85. WaxenbaumJA. ReddyV. VaracalloM. Anatomy, autonomic nervous system.StatPearls.United StatesStatPearls Publishing2023
     [Google Scholar]
  86. KumarS. PaliwalD. SahuR. KaushikN. Recent Advancements in the Synthesis of Pyrazole Derivative for the Treatment of Alzheimer’s Disease.Curr. Org. Chem.202529181409142310.2174/0113852728360592250214110907
     [Google Scholar]
  87. SharonN. UgaleV.G. PadmajaP. LokwaniD. SalunkheC. SheteP. ReddyP.N. KulkarniP.P. Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer’s disease.Mol. Divers.202529137939610.1007/s11030‑024‑10859‑z 38683486
     [Google Scholar]
  88. FaghihZ. KhabnadidehS. SakhtemanA. ShiraziA.K. YariH.A. ChatraeiA. RezaeiZ. SadeghianS. Synthesis, biological evaluation and molecular modeling studies of novel carbazole-benzylpiperazine hybrids as acetylcholinesterase and butyrylcholinesterase inhibitors.J. Mol. Struct.2023127213420910.1016/j.molstruc.2022.134209
     [Google Scholar]
  89. SongM. MinW. WangJ. SiX.X. WangX.J. LiuY.W. ShiD.H. Design, synthesis and biological evaluation of new carbazole-coumarin hybrids as dual binding site inhibitors of acetylcholinesterase.J. Mol. Struct.2021122912978410.1016/j.molstruc.2020.129784
     [Google Scholar]
  90. PatelD.V. PatelN.R. KanhedA.M. TeliD.M. PatelK.B. JoshiP.D. PatelS.P. GandhiP.M. ChaudharyB.N. PrajapatiN.K. PatelK.V. YadavM.R. Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents.Bioorg. Chem.202010110397710.1016/j.bioorg.2020.103977 32485470
     [Google Scholar]
  91. FuP. SunW. ZhangZ. Molecular cloning, expression and characterization of acylpeptide hydrolase in the silkworm, Bombyx mori.Gene2016580181610.1016/j.gene.2015.12.069 26778207
     [Google Scholar]
  92. VenäläinenJ.I. JuvonenR.O. MännistöP.T. Evolutionary relationships of the prolyl oligopeptidase family enzymes.Eur. J. Biochem.2004271132705271510.1111/j.1432‑1033.2004.04199.x 15206935
     [Google Scholar]
  93. HannulaM.J. MyöhänenT.T. Tenorio-LarangaJ. MännistöP.T. Garcia-HorsmanJ.A. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases.Neuroscience201324214015010.1016/j.neuroscience.2013.03.049 23562579
     [Google Scholar]
  94. AlvarezV.E. NiemirowiczG.T. CazzuloJ.J. The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death.Biochim. Biophys. Acta. Proteins Proteomics20121824119520610.1016/j.bbapap.2011.05.011 21621652
     [Google Scholar]
  95. UllahS. MansoorF. KhanS.A. JabeenU. AlmarsA.I. AlmohaimeedH.M. BasriA.M. AlshabrmiF.M. Exploring bi-carbazole-linked triazoles as inhibitors of prolyl endo peptidase via integrated in vitro and in silico study.Sci. Rep.2024141767510.1038/s41598‑024‑58428‑6 38561470
     [Google Scholar]
  96. MacLeanR.C. San MillanA. The evolution of antibiotic resistance.Science201936564581082108310.1126/science.aax3879 31515374
     [Google Scholar]
  97. BakkerenE. DiardM. HardtW.D. Evolutionary causes and consequences of bacterial antibiotic persistence.Nat. Rev. Microbiol.202018947949010.1038/s41579‑020‑0378‑z 32461608
     [Google Scholar]
  98. KoulentiD. XuE. Yin Sum MokI. SongA. KarageorgopoulosD.E. ArmaganidisA. LipmanJ. TsiodrasS. Novel antibiotics for multidrug-resistant gram-positive microorganisms.Microorganisms20197827010.3390/microorganisms7080270 31426596
     [Google Scholar]
  99. ChenC.H. LiuC.S. GuoX.M. TongJ.P. HuangJ. ShiT.T. SunJ. Design, synthesis, and biological evaluation of carbazole derivatives as potent antibacterial agents targeting membrane function via FabH Inhibition.J. Mol. Struct.2024130613789110.1016/j.molstruc.2024.137891
     [Google Scholar]
  100. MaS.Y. DingY.G. TuoX.X. WangG.Q. LiuH.W. MengJ. ZhangT.H. LiuL.W. QiP.Y. ZhouX. YangS. Design, synthesis, and evaluation of novel 3-(piperazin-1-yl)propan-2-ol-modified carbazole derivatives targeting the bacterial membrane.Arab. J. Chem.202417910585010.1016/j.arabjc.2024.105850
     [Google Scholar]
  101. AshokD. TharaG. KumarB.K. SrinivasG. RavinderD. VishnuT. SarasijaM. SushmithaB. Microwave-assisted synthesis, molecular docking studies of 1,2,3-triazole-based carbazole derivatives as antimicrobial, antioxidant and anticancer agents.RSC Advances2022131254010.1039/D2RA05960F 36545291
     [Google Scholar]
  102. NiedziałkowskaK. FelczakA. GłowackaI.E. PiotrowskaD.G. LisowskaK. Antimicrobial activity and toxicity of newly synthesized 4-[4-(benzylamino)butoxy]-9H-carbazole derivatives.Int. J. Mol. Sci.202324181372210.3390/ijms241813722 37762024
     [Google Scholar]
  103. SabalePM Design, synthesis and biological screening of novel carbazole tethered oxyethylamino derivatives as antimicrobial agent.Ind. J. Pharm. Edu Res202357
     [Google Scholar]
  104. MerzoukiO. ArrousseN. El BarnossiA. Ech-chihbiE. FernineY. Iraqi Housseini, A.; Rais, Z.; Taleb, M. Eco-friendly synthesis, characterization, in-silico ADMET and molecular docking analysis of novel carbazole derivatives as antibacterial and antifungal agents.J. Mol. Struct.2023127113396610.1016/j.molstruc.2022.133966
     [Google Scholar]
  105. ÜnverY. SüleymanoğluN. UstabaşR. BektaşK.İ. BektaşE. GülerH.İ. 3-(5-(1 H-imidazol-1-yl) pent-1-en-1-yl)-9-ethyl-9 H -carbazole: Synthesis, characterization (IR, NMR), DFT, antimicrobial-antioxidant activities and docking study.J. Biomol. Struct. Dyn.20224023129901300010.1080/07391102.2021.1977708 34514967
     [Google Scholar]
  106. ShaikhM.S. KanhedA.M. ChandrasekaranB. PalkarM.B. AgrawalN. LherbetC. HampannavarG.A. KarpoormathR. Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA.Bioorg. Med. Chem. Lett.201929162338234410.1016/j.bmcl.2019.06.015 31227345
     [Google Scholar]
  107. BashirM.K. MustafaY.F. OglahM.K. Synthesis and antitumor activity of new multifunctional coumarins.Periód. Tchê Quím.2020173687188310.52571/PTQ.v17.n36.2020.886_Periodico36_pgs_871_883.pdf
     [Google Scholar]
  108. MarufaS.S. RahmanM.M. RahmanM.M. DebnathJ.R. MimM.A. JahanR. NishinoH. AlamM.S. HaqueM.A. Conventional and microwave-assisted synthesis, antimicrobial and antioxidant activity evaluation with in silico studies of carbazole-thiazole-Schiff base hybrids.J. Mol. Struct.2025132113986110.1016/j.molstruc.2024.139861
     [Google Scholar]
  109. AlothmanS. KandilF. DeepA. Carbazole derivatives as antioxidant and anticorrosion materials.Results Chem.2024910166710.1016/j.rechem.2024.101667
     [Google Scholar]
  110. MarufaS.S. RahmanM.M. RahmanM. JahanR. AraG. NishinoH. AlamM.S. HaqueM.A. Synthesis, antimicrobial and antioxidant activity with in silico ADMET prediction, molecular docking and dynamics studies of carbazole ring containing thiazole Schiff bases.Asian J. Org. Chem.2024131220240036310.1002/ajoc.202400363
     [Google Scholar]
  111. AbbasZ.M. ThejeelK.A. AliS.A. MubarakH.A. LihumisH.S. Synthesis, design, biological and anti-oxidant assessment of some new 9H-carbazole derivatives.J. Pak Inst. Chem. Eng.202351210.54693/piche.05123
     [Google Scholar]
  112. DumitrascuF. CairaM.R. AvramS. BuiuC. UdreaA.M. VladI.M. ZarafuI. IonițăP. NuțăD.C. PopaM. ChifiriucM.C. LimbanC. Repurposing anti-inflammatory drugs for fighting planktonic and biofilm growth. New carbazole derivatives based on the NSAID carprofen: Synthesis, in silico and in vitro bioevaluation.Front. Cell. Infect. Microbiol.202313118151610.3389/fcimb.2023.1181516 37680749
     [Google Scholar]
  113. RossD.S. BurchH.B. CooperD.S. GreenleeM.C. LaurbergP. MaiaA.L. RivkeesS.A. SamuelsM. SosaJ.A. StanM.N. WalterM.A. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.Thyroid201626101343142110.1089/thy.2016.0229 27521067
     [Google Scholar]
  114. SawinC.T. CooperD.S. The origin of antithyroid drugs.Thyroid202333121395140110.1089/thy.2022.0410 37594736
     [Google Scholar]
  115. CooperD.S. Antithyroid drugs in the management of patients with Graves’ disease: An evidence-based approach to therapeutic controversies.J. Clin. Endocrinol. Metab.20038883474348110.1210/jc.2003‑030185 12915620
     [Google Scholar]
  116. RaniP. In vitro assessment to evaluate the anti-thyroid potential of selected carbazole derivatives.MSW Manag. J.2024341350366
     [Google Scholar]
  117. CaoS. ZhangX. EdwardsJ.P. MosserD.M. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages.J. Biol. Chem.200628136260412605010.1074/jbc.M602222200 16835236
     [Google Scholar]
  118. AokiT. NarumiyaS. Prostaglandins and chronic inflammation.Trends Pharmacol. Sci.201233630431110.1016/j.tips.2012.02.004 22464140
     [Google Scholar]
  119. MittalM. SiddiquiM.R. TranK. ReddyS.P. MalikA.B. Reactive oxygen species in inflammation and tissue injury.Antioxid. Redox Signal.20142071126116710.1089/ars.2012.5149 23991888
     [Google Scholar]
  120. Iqbal AndrabiN. SarkarA.R. Assim HaqS. kumar, D.; Kour, D.; Saroch, D.; Kumar Shukla, S.; Kumar, A.; Bhagat, A.; Ali, A.; Kour, G.; Ahmed, Z. Site-selective synthesis and pharmacological elucidation of novel semi-synthetic analogues of koenimbine as a potential anti-inflammatory agent.Int. Immunopharmacol.202412611105910.1016/j.intimp.2023.111059 37979450
     [Google Scholar]
  121. PerlisM.L. PosnerD. RiemannD. BastienC.H. TeelJ. InsomniaT.M. Insomnia.Lancet4001035710471060
     [Google Scholar]
  122. OhD.R. KimY. JoA. ChoiE.J. OhK.N. KimJ. KangH. KimY.R. ChoiC. Sedative and hypnotic effects of Vaccinium bracteatum Thunb. through the regulation of serotonegic and GABAA-ergic systems: Involvement of 5-HT1A receptor agonistic activity.Biomed. Pharmacother.20191092218222710.1016/j.biopha.2018.10.003 30551479
     [Google Scholar]
  123. LovatoN. LackL. Insomnia and mortality: A meta-analysis.Sleep Med. Rev.201943718310.1016/j.smrv.2018.10.004 30529432
     [Google Scholar]
  124. SuX.X. ChenY.R. WuJ.Q. WuX.Z. LiK.T. WangX.N. SunJ.W. WangH. OuT.M. Design, synthesis, and evaluation of 9-(pyrimidin-2-yl)-9H-carbazole derivatives disrupting mitochondrial homeostasis in human lung adenocarcinoma.Eur. J. Med. Chem.202223211420010.1016/j.ejmech.2022.114200 35219149
     [Google Scholar]
  125. NaidooJ. De Jesus-CortesH. HuntingtonP. EstillS. MorlockL.K. StarwaltR. ManganoT.J. WilliamsN.S. PieperA.A. ReadyJ.M. Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyri-din-2-amine [(-)-P7C3-S243], with improved druglike properties.J. Med. Chem.20145793746375410.1021/jm401919s 24697290
     [Google Scholar]
  126. BertiniS. AssoV. GhilardiE. GranchiC. ManeraC. MinutoloF. SaccomanniG. BortolatoA. MasonJ. MoroS. MacchiaM. Carbazole-containing arylcarboxamides as BACE1 inhibitors.Bioorg. Med. Chem. Lett.201121226657666110.1016/j.bmcl.2011.09.064 21986588
     [Google Scholar]
  127. LiZ. FangF. LiY. LvX. ZhengR. JiaoP. WangY. ZhuG. JinZ. XuX. QiuY. ZhangG. LiZ. LiuZ. ZhangL. Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties.Acta Pharm. Sin. B202313114553457710.1016/j.apsb.2023.07.024 37969740
     [Google Scholar]
  128. XuT. LiF. FengZ. DangC. YangY. WangJ. ZangC.X. BaoX.Q. YuS.S. ZhangD. WangR.B. Design, synthesis and evaluation of pyrimidine derivatives as sedative-hypnotic agents.Eur. J. Med. Chem.202528411721310.1016/j.ejmech.2024.117213 39742697
     [Google Scholar]
/content/journals/mrmc/10.2174/0113895575407122250822095143
Loading
Current Developments in the Pharmacological Activities and Synthesis of Carbazole Derivatives
Mini Rev Med Chem 25, 1334 (2025); https://doi.org/10.2174/0113895575407122250822095143
/content/journals/mrmc/10.2174/0113895575407122250822095143
/content/journals/mrmc/10.2174/0113895575407122250822095143
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): anti-alzheimer; anti-inflammatory; anticancer; antidiabetic; antithyroid; carbazole; Synthesis; treatment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test